Theranos Under The Microscope
A Wall Street Journal reporter talks to CBS about how the once promising startup is now struggling.
Why Much-Hyped Biotech Company Is Fighting To Save Its Reputation
Theranos, one of the rising stars in biotech, is battling to save its reputation. Just last year, founder and CEO Elizabeth Holmes was featured among Time magazine's "100 Most Influential People." Her company promised to offer hundreds of fast, cheap and accurate blood tests, using a few drops of blood, rather than vials. But a series of articles in the Wall Street Journal raised questions about its technology and lab practices, and the Silicon Valley startup is now under review by two federal regulators. (3/9)